Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer

被引:0
|
作者
Hiroki Goya
Hiroshi Kuraishi
Shigeru Koyama
Takashi Ichiyama
Fumiaki Yoshiike
Kazuya Hirai
Toshihiko Agatsuma
Kazunari Tateishi
Shintaro Kanda
Hiroshi Yamamoto
Keishi Kubo
Tomonobu Koizumi
机构
[1] Nagano Red Cross Hospital,Respiratory Division
[2] Nagano Municipal Hospital,Respiratory Division
[3] Shinshu University School of Medicine,First Department of Internal Medicine
[4] Shinshu University Hospital School of Medicine,Division of Clinical Oncology, Comprehensive Cancer Center
来源
关键词
Chemo-refractory; Salvage chemotherapy; Second line; CTP-11;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:691 / 697
页数:6
相关论文
共 50 条
  • [31] Phase I/II study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer
    Tamura, Kenji
    Okamoto, Isamu
    Ozaki, Tomohiro
    Kashii, Tatsuhiko
    Takeda, Koji
    Kobayashi, Masashi
    Matsui, Kaoru
    Shibata, Takashi
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    Fukuoka, Masahiro
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (12) : 2132 - 2137
  • [32] A phase II study of S-1 for previously treated small cell lung cancer (SCLC)
    Kudo, K.
    Ohyanagi, F.
    Horiike, A.
    Miyauchi, E.
    Motokawa, I.
    Horai, T.
    Mun, M.
    Sakao, Y.
    Okumura, S.
    Nakagawa, K.
    Nishio, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] PHASE II STUDY OF IRINOTECAN PLUS S-1 COMBINATION FOR PREVIOUSLY UNTREATED ADVANCED NON-SMALL CELL LUNG CANCER: HOKKAIDO LUNG CANCER CLINICAL STUDY GROUP TRIAL 0601
    Oizumi, S.
    Akie, K.
    Ogura, S.
    Shinagawa, N.
    Fukumoto, S.
    Harada, M.
    Akita, H.
    Isobe, H.
    Nishimura, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 156 - 156
  • [34] A phase II study of weekly irinotecan and capecitabine in patients with previously treated non-small cell lung cancer
    Han, JY
    Lee, DH
    Kim, HY
    Kim, EA
    Lee, JJ
    Ju, SY
    Shin, EH
    Lee, JS
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 5909 - 5914
  • [35] Phase I study of irinotecan and gemcitabine in previously untreated, patients with advanced non-small cell lung cancer
    Takatani, Hiroshi
    Soda, Hiroshi
    Nakamura, Yoichi
    Kinoshita, Akitoshi
    Fukuda, Masaaki
    Nagashima, Seiji
    Fukuda, Minoru
    Soejima, Yoshifumi
    Nakano, Hirofumi
    Oka, Mikio
    Kohno, Shigeru
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (05) : 353 - 357
  • [36] Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer
    Nanae Tomonaga
    Yoichi Nakamura
    Hiroshi Soda
    Seiji Nagashima
    Hirofumi Nakano
    Akitoshi Kinoshita
    Masaaki Fukuda
    Minoru Fukuda
    Hiroshi Takatani
    Yoshifumi Soejima
    Mikio Oka
    Shigeru Kohno
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 43 - 49
  • [37] Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer
    Tomonaga, Nanae
    Nakamura, Yoichi
    Soda, Hiroshi
    Nagashima, Seiji
    Nakano, Hirofumi
    Kinoshita, Akitoshi
    Fukuda, Masaaki
    Fukuda, Minoru
    Takatani, Hiroshi
    Soejima, Yoshifumi
    Oka, Mikio
    Kohno, Shigeru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) : 43 - 49
  • [38] Phase II Study of Biweekly Pemetrexed and Gemcitabine in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer
    Spigel, David R.
    Hainsworth, John D.
    Barton, John H.
    Patton, Jeffrey F.
    Zubkus, John D.
    Simons, Lisa
    Griner, Paula
    Burris, Howard A., III
    Greco, F. Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : 841 - 845
  • [39] Final results of a phase II trial of S-1 with biweekly docetaxel for non-small cell lung cancer previously treated with platinum-based chemotherapy (NJLCG0701)
    Ishimoto, O.
    Sakakibara, T.
    Maemondo, M.
    Morikawa, N.
    Okudera, K.
    Usul, K.
    Suzuki, T.
    Inoue, A.
    Nukiwa, T.
    Sugawara, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Phase II Study of S-1 and Vinorelbine in Patients With Advanced Non-small Cell Lung Cancer
    Kodani, M.
    Kinoshit, N.
    Ueda, Y.
    Suyama, H.
    Sumikawa, T.
    Makin, H.
    Kurai, J.
    Matsumoto, S.
    Igishi, T.
    Shimizu, E.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S620 - S620